Gene · 4100
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular Vesicles in Blood: Sources, Effects, and Applications. | Int J Mol Sci | 2021 | 34360924 | PubTator, text mining | PubMed |
| Autoimmune Responses in Oncology: Causes and Significance. | Int J Mol Sci | 2021 | 34360795 | PubTator, text mining | PubMed |
| Cancer-Testis Antigens in Triple-Negative Breast Cancer: Role and Potential Utility in Clinical Practice. | Cancers (Basel) | 2021 | 34359776 | PubTator, text mining | PubMed |
| Immunotherapy in Glioblastoma: A Clinical Perspective. | Cancers (Basel) | 2021 | 34359621 | PubTator, text mining | PubMed |
| DC-Derived Exosomes for Cancer Immunotherapy. | Cancers (Basel) | 2021 | 34359569 | PubTator, text mining | PubMed |
| Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia. | Pharmaceuticals (Basel) | 2021 | 34358067 | PubTator, text mining | PubMed |
| Deregulation of HLA-I in cancer and its central importance for immunotherapy. | J Immunother Cancer | 2021 | 34353849 | PubTator, text mining | PubMed |
| The splicing regulator SLU7 is required to preserve DNMT1 protein stability and DNA methylation. | Nucleic Acids Res | 2021 | 34331453 | PubTator, text mining | PubMed |
| Clinical translation of immunomodulatory therapeutics. | Adv Drug Deliv Rev | 2021 | 34324885 | PubTator, text mining | PubMed |
| Telomerase as a Target for Therapeutic Cancer Vaccines and Considerations for Optimizing Their Clinical Potential. | Front Immunol | 2021 | 34290704 | PubTator, text mining | PubMed |
| Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma. | Nature | 2021 | 34290406 | PubTator, text mining | PubMed |
| The role of seven autoantibodies in lung cancer diagnosis. | J Thorac Dis | 2021 | 34277058 | PubTator, text mining | PubMed |
| Recent Advances and Future Perspective of DC-Based Therapy in NSCLC. | Front Immunol | 2021 | 34262573 | PubTator, text mining | PubMed |
| SFPQ promotes an oncogenic transcriptomic state in melanoma. | Oncogene | 2021 | 34218270 | PubTator, text mining | PubMed |
| Effects of a Novel Thiadiazole Derivative with High Anticancer Activity on Cancer Cell Immunogenic Markers: Mismatch Repair System, PD-L1 Expression, and Tumor Mutation Burden. | Pharmaceutics | 2021 | 34203761 | PubTator, text mining | PubMed |
| Epigenetic Upregulation of MAGE-A Isoforms Promotes Breast Cancer Cell Aggressiveness. | Cancers (Basel) | 2021 | 34202157 | PubTator, text mining | PubMed |
| MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It. | Int J Mol Sci | 2021 | 34201655 | PubTator, text mining | PubMed |
| T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors. | J Hematol Oncol | 2021 | 34193217 | PubTator, text mining | PubMed |
| T-Cell Receptor Mimic Antibodies for Cancer Immunotherapy. | Mol Cancer Ther | 2021 | 34172530 | PubTator, text mining | PubMed |
| Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma. | PLoS Genet | 2021 | 34166362 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4100/papers?page=19